Trial Details
COMPLETEDBasic Information
| Clinical ID | c2227 |
|---|---|
| Identifier | NCT03817645 |
| Trial Title | Panaceo MED for IBS (Irritable Bowel Syndrome) |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Irritable Bowel Syndrome|Microbial Colonization|Intestinal Disease |
| Interventions | OTHER: Zeolite |
Participant Information
| Sponsor | Scigenia GmbH |
|---|---|
| City | Vienna |
| Country/Region | Austria |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | NA |
Time Information
| Start Date | 2018-03-09 |
|---|---|
| Primary Completion Date | 2019-06-30 |
| Completion Date | 2020-06-30 |